Get the latest tech news

FDA says 561 deaths tied to recalled Philips sleep apnea machines

Update from the Food and Drug Agency comes days after Philips said it would stop selling the devices in the U.S.

The grim tally comes days after Philips said it would stop selling the machines in the U.S. in a settlement with the FDA and the Justice Department expected to cost roughly $400 million, the company disclosed in a regulatory filing. Claims for financial losses related to the purchase, lease or rent of the recalled machines can be now be lodged in the wake of a proposed class-action settlement reached in September. Roughly 30 million people have sleep apnea, a disorder in which one's airways become blocked during rest, interrupting breathing, according to 2022 data from the American Medical Association.

Get the Android app